Post by
Hopeful123 on Mar 24, 2024 5:32pm
Labs or Avicanna
Who has a better chance of being acquired.
Comment by
Olaf123 on Mar 27, 2024 12:51pm
I think they had a discussion but could not agree. Medipharm has 2 year or more (their cash burn rate is slowing meaningfully) left of operating money. Avicanna owes a lot of money (payables), had 700k cash end of q3 +900k from placement (1.6M). We will see April 1.
Comment by
Hopeful123 on Mar 27, 2024 6:41pm
With Avicanna owing so much money it seems unlikely they will be cash flow positive for years...Guess AA is having trouble sleeping now as he had expected this to happen sooner...Also soon Avcn will have to raise money again...